Post-IPO Equity Pharmaceutical Companies

Lumito is a medical device and technology licensing company located in Lund, Skane County, Sweden.

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.

Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.

AEON Biopharma is a biopharmaceutical company that develops novel and proprietary treatment paradigms to improve patient outcomes.

Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.

Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.

Salarius Pharmaceuticals is an oncology-based biotechnology company developing new therapies to address gene dysregulation.

Isla Pharmaceuticals is a biotechnology company that develops tropical disease therapies.

Avenue Therapeutics is a specialty pharmaceutical company that acquires/in-licenses, develops and commercializes products.

Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

Pila Pharma is a TRPV1-platform focused company developing oral treatments for type-2 diabetes, obesity, and pain.

Kiromic develops biomarker- and small molecule-based diagnostic and therapeutic programs for solid tumors and hematologic malignancies.

Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.

Ultimovacs is a pharmaceutical company developing novel immunotherapies against cancer.

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

BullFrog AI is a developer of an artificial intelligence platform intended to help companies in clinical development.

Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.

Fluicell is one of the manufacturers of fluid platforms for multifunctional pipettes.

Adagio Medical is engaged in the research and development of treatments for cardiovascular diseases.

TAO Synergies is a clinical-stage biopharmaceutical company that develops novel therapies for neurodegenerative diseases.

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders.